Price, DavidMenzies-Gow, Andrew NBachert, ClausCanonica, Giorgio WalterKocks, Janwillem W HKhan, Asif H.Ye, FengRowe, PaulLu, YufangKamat, SiddheshCarter, VictoriaVoorham, Jaco2021-09-292021-09-292021-09-29Price, D, Menzies-Gow, A N, Bachert, C, Canonica, G W, Kocks, J W H, Khan, A H, Ye, F, Rowe, P, Lu, Y, Kamat, S, Carter, V & Voorham, J 2021, 'Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma', Journal of Asthma and Allergy, vol. 2021, no. 14, pp. 1173—1183. https://doi.org/10.2147/JAA.S3212121178-6965SCOPUS: 85116490641https://hdl.handle.net/2164/17206Funding This study was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. Acknowledgments At the time of development of this manuscript, Fen Ye was an employee of Sanofi and Yufang Lu was an employee of Regeneron Pharmaceuticals.Medical writing support was provided by Abby Armitt, MSc, and Gauri Saal, MA Economics, of Prime, Knutsford, UK, and funded by Sanofi and Regeneron Pharmaceuticals, Inc.111029255engtype 2 inflammationasthmaexacerbationscontrolburdencomorbiditiesR MedicineRJournal article10.2147/JAA.S32121214